Japan Approves Bayer Yakuhin Yaz For PMDD
This article was originally published in PharmAsia News
Executive Summary
The Ministry of Health, Labor and Welfare approved Osaka-based Bayer Yakuhin to manufacture and market Yaz (ethinyl estradiol/drospirenone) for premenstrual dysphoric disorder